Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raimondo Bruno

Showing results (131-140 of 267) with videos related to

Pageof 27
Sort By:
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
Journal of Psychopharmacology (Oxford, England)|June 30, 2017
Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospectsAndrew C Parrott, Luke A Downey, Carl A Roberts, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 25, 2015
Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) studySuzanne Nielsen, Gabrielle Campbell, Amy Peacock, et al.
Research in Social & Administrative Pharmacy : RSAP|April 11, 2020
Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot studySuzanne Nielsen, Louisa Picco, Michala Kowalski, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 29, 2020
Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSDLuke J Ney, Jane Akhurst, Raimondo Bruno, et al.
Pain Medicine (Malden, Mass.)|October 9, 2019
Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care SettingsSuzanne Nielsen, Louisa Picco, Gabrielle Campbell, et al.
The International Journal on Drug Policy|July 1, 2015
Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulationAmy Peacock, Louisa Degenhardt, Antonia Hordern, et al.
Drug and Alcohol Dependence|July 20, 2016
Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary studyAmy Peacock, Raimondo Bruno, Briony Larance, et al.
Substance Abuse Treatment, Prevention, and Policy|October 8, 2022
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorderLlewellyn Mills, Adrian Dunlop, Mark Montebello, et al.
Drug and Alcohol Review|October 2, 2015
Co-ingestion of energy drinks with alcohol and other substances among a sample of people who regularly use ecstasyAmy Peacock, Natasha Sindicich, Matthew Dunn, et al.
Pageof 27

Showing results (131-140 of 267) with videos related to

Sort By:
Pageof 27
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
Journal of Psychopharmacology (Oxford, England)|June 30, 2017
Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospectsAndrew C Parrott, Luke A Downey, Carl A Roberts, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 25, 2015
Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) studySuzanne Nielsen, Gabrielle Campbell, Amy Peacock, et al.
Research in Social & Administrative Pharmacy : RSAP|April 11, 2020
Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot studySuzanne Nielsen, Louisa Picco, Michala Kowalski, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 29, 2020
Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSDLuke J Ney, Jane Akhurst, Raimondo Bruno, et al.
Pain Medicine (Malden, Mass.)|October 9, 2019
Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care SettingsSuzanne Nielsen, Louisa Picco, Gabrielle Campbell, et al.
The International Journal on Drug Policy|July 1, 2015
Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulationAmy Peacock, Louisa Degenhardt, Antonia Hordern, et al.
Drug and Alcohol Dependence|July 20, 2016
Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary studyAmy Peacock, Raimondo Bruno, Briony Larance, et al.
Substance Abuse Treatment, Prevention, and Policy|October 8, 2022
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorderLlewellyn Mills, Adrian Dunlop, Mark Montebello, et al.
Drug and Alcohol Review|October 2, 2015
Co-ingestion of energy drinks with alcohol and other substances among a sample of people who regularly use ecstasyAmy Peacock, Natasha Sindicich, Matthew Dunn, et al.
Pageof 27